Literature DB >> 11746984

Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7.

Thomas Mercher1, Maryvonne Busson-Le Coniat, Florence Nguyen Khac, Paola Ballerini, Martine Mauchauffé, Hung Bui, Béatrice Pellegrino, Isabelle Radford, Françoise Valensi, Francine Mugneret, Nicole Dastugue, Olivier A Bernard, Roland Berger.   

Abstract

Translocation t(1;22)(p13;q13) is associated with a peculiar subtype of acute megakaryocytic leukemia (M7) occurring in infants. We have recently characterized a fusion gene, OTT-MAL, resulting from this translocation. We now report three additional cases and show that this gene fusion is present in all five t(1;22) cases studied to date. Nucleotide sequence analysis of two translocation breakpoints suggests a nonhomologous end joining mechanism in the genesis of this translocation and reveals a noncanonical topoisomerase II-like consensus sequence within the OTT gene. FISH and PCR techniques described in this work are useful for identifying t(1;22) associated with M7.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11746984     DOI: 10.1002/gcc.1208

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  18 in total

1.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

2.  MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation.

Authors:  Elenoe C Smith; Jonathan N Thon; Matthew T Devine; Sharon Lin; Vincent P Schulz; Yanwen Guo; Stephanie A Massaro; Stephanie Halene; Patrick Gallagher; Joseph E Italiano; Diane S Krause
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

Review 3.  Genomic landscape of megakaryopoiesis and platelet function defects.

Authors:  Elisa Bianchi; Ruggiero Norfo; Valentina Pennucci; Roberta Zini; Rossella Manfredini
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

Review 4.  GATA factor mutations in hematologic disease.

Authors:  John D Crispino; Marshall S Horwitz
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 5.  Linking actin dynamics and gene transcription to drive cellular motile functions.

Authors:  Eric N Olson; Alfred Nordheim
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05       Impact factor: 94.444

6.  Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation.

Authors:  Ting Liu; Zhenxing Zhang; Chunjie Yu; Chang Zeng; Xiaoqing Xu; Guixian Wu; Zan Huang; Wenhua Li
Journal:  Br J Pharmacol       Date:  2017-11-02       Impact factor: 8.739

7.  The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.

Authors:  Thomas Mercher; Glen D Raffel; Sandra A Moore; Melanie G Cornejo; Dominique Baudry-Bluteau; Nicolas Cagnard; Jonathan L Jesneck; Yana Pikman; Dana Cullen; Ifor R Williams; Koichi Akashi; Hirokazu Shigematsu; Jean-Pierre Bourquin; Marco Giovannini; William Vainchenker; Ross L Levine; Benjamin H Lee; Olivier A Bernard; D Gary Gilliland
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

8.  Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation.

Authors:  Xianyong Ma; Matthew J Renda; Lin Wang; Ee-Chun Cheng; Chao Niu; Stephan W Morris; Andrew S Chi; Diane S Krause
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.

Authors:  Jasmijn D E de Rooij; Riccardo Masetti; Marry M van den Heuvel-Eibrink; Jean-Michel Cayuela; Jan Trka; Dirk Reinhardt; Mareike Rasche; Edwin Sonneveld; Todd A Alonzo; Maarten Fornerod; Martin Zimmermann; Martina Pigazzi; Rob Pieters; Soheil Meshinchi; C Michel Zwaan; Franco Locatelli
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

10.  OTT-MAL is a deregulated activator of serum response factor-dependent gene expression.

Authors:  Arnaud Descot; Monika Rex-Haffner; Geneviève Courtois; Dominique Bluteau; Antje Menssen; Thomas Mercher; Olivier A Bernard; Richard Treisman; Guido Posern
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.